Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Itamar Medical stock

ITMR.TA
IL0011024580
A1CZAF

Price

0
Today +/-
-0
Today %
-0 %

Itamar Medical stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Itamar Medical stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Itamar Medical stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Itamar Medical stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Itamar Medical's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Itamar Medical Stock Price History

DateItamar Medical Price
12/19/20210 undefined
12/19/20210 undefined

Itamar Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Itamar Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Itamar Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Itamar Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Itamar Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Itamar Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Itamar Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Itamar Medical’s growth potential.

Itamar Medical Revenue, EBIT and net profit per share

DateItamar Medical RevenueItamar Medical EBITItamar Medical Net Income
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20060 undefined0 undefined0 undefined
20050 undefined0 undefined0 undefined
20040 undefined0 undefined0 undefined
20030 undefined0 undefined0 undefined

Itamar Medical Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
200320042005200620072008200920102011201220132014201520162017201820192020
000000000000000000
------------------
------------------
000000000000000000
000000000000000000
------------------
000000000000000000
------------------
Details

Keystats

ⓘ

Revenue and Growth

The Itamar Medical Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Itamar Medical is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20042005200620072008200920102011201220132014201520162017201820192020
                                 
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
                                 
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
00000000000000000
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Itamar Medical provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Itamar Medical's financial health and stability.

Assets

Itamar Medical's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Itamar Medical must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Itamar Medical after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Itamar Medical's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
200320042005200620072008200920102011201220132014201520162017201820192020
000000000000000000
000000000000000000
000000000000000000
000000000000000000
000000000000000000
000000000000000000
000000000000000000
000000000000000000
000000000000000000
000000000000000000
000000000000000000
000000000000000000
000000000000000000
000000000000000000
000000000000000000
------------------
000000000000000000
000000000000000000
000000000000000000
000000000000000000

Itamar Medical stock margins

The Itamar Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Itamar Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Itamar Medical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Itamar Medical's sales revenue. A higher gross margin percentage indicates that the Itamar Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Itamar Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Itamar Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Itamar Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Itamar Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Itamar Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Itamar Medical Margin History

Itamar Medical Gross marginItamar Medical Profit marginItamar Medical EBIT marginItamar Medical Profit margin
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %
20140 %0 %0 %
20130 %0 %0 %
20120 %0 %0 %
20110 %0 %0 %
20100 %0 %0 %
20090 %0 %0 %
20080 %0 %0 %
20070 %0 %0 %
20060 %0 %0 %
20050 %0 %0 %
20040 %0 %0 %
20030 %0 %0 %

Itamar Medical Stock Sales Revenue, EBIT, Earnings per Share

The Itamar Medical earnings per share therefore indicates how much revenue Itamar Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Itamar Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Itamar Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Itamar Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Itamar Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Itamar Medical Revenue, EBIT and net profit per share

DateItamar Medical Sales per ShareItamar Medical EBIT per shareItamar Medical Earnings per Share
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20060 undefined0 undefined0 undefined
20050 undefined0 undefined0 undefined
20040 undefined0 undefined0 undefined
20030 undefined0 undefined0 undefined

Itamar Medical business model

Itamar Medical Ltd is a company specialized in the development and marketing of non-invasive diagnostic and monitoring solutions for sleep disorders, heart diseases, and peripheral vascular diseases. The company was founded in Israel in 1997. The history of Itamar Medical begins with the development of the PAT system (Peripheral Arterial Tone), a device that uses the peripheral arterial tonometer to measure blood flow. With this system, doctors were able to record patients' sleep for the first time and diagnose sleep disorders such as obstructive sleep apnea syndrome (OSAS) or restless leg syndrome (RLS). Over the years, the company has expanded its offerings and developed various solutions to improve the diagnosis and monitoring of heart and vascular diseases. Itamar Medical's products now include the EndoPAT, WatchPAT, and Total Sleep Solution, among others. The EndoPAT is a non-invasive medical device that measures the endothelial function state of patients. This refers to the ability of blood vessels to dilate when needed to increase blood flow. The EndoPAT allows doctors to assess the cardiovascular health status of patients and predict the risk of cardiovascular diseases. The WatchPAT is a wearable sleep monitor that wirelessly connects to an app. The device records the sleep architecture of patients and automatically detects sleep apnea episodes, which are then displayed on the app. The WatchPAT enables doctors to improve the sleep quality of patients and diagnose sleep disorders. Itamar Medical's Total Sleep Solution offers a comprehensive solution for the management of sleep disorders. The solution includes the WatchPAT tracker, the PAT procedures for sleep disorder diagnosis, and the EndoPAT procedures for assessing cardiovascular health. This combination of technologies allows doctors to treat their patients holistically and improve their cardiovascular health and sleep quality. Itamar Medical has also formed partnerships with other companies to enhance its solutions and promote new developments. Currently, the company is collaborating with Teva Pharmaceutical Industries to develop a new formulation of Sildenafil, a medication used for treating erectile dysfunction. Overall, Itamar Medical has experienced strong growth in recent years. The company has branches in the USA, Europe, and Asia and is constantly working to expand its offerings and improve its technology for the diagnosis and monitoring of heart and sleep disorders. In summary, Itamar Medical is an innovative provider of non-invasive diagnostic and monitoring solutions for sleep disorders, heart diseases, and peripheral vascular diseases. With its wide range of products and partnerships with other companies, the company is well-positioned to continue growing and expanding in the coming years. Itamar Medical is one of the most popular companies on Eulerpool.com.

Itamar Medical SWOT Analysis

Strengths

1. Advanced Medical Technologies: Itamar Medical Ltd is known for its innovative medical devices, particularly in the field of sleep apnea diagnosis and management. Their cutting-edge technologies provide accurate and reliable results, enabling healthcare providers to deliver better patient care.

2. Strong Market Presence: The company has established a strong market presence globally, with a wide distribution network and collaborations with healthcare institutions. This enables them to reach a large customer base and maintain a competitive edge.

3. Experienced Management Team: Itamar Medical Ltd is supported by a team of experienced professionals who have extensive knowledge and expertise in the healthcare industry. This leadership ensures effective decision-making and strategic planning.

Weaknesses

1. Dependence on Specific Product Segments: The company relies heavily on its sleep apnea diagnostic products, which may pose a risk if there is a decline in demand or if competitors introduce similar products. Diversification into other medical segments could mitigate this weakness.

2. Limited Geographical Reach: Although Itamar Medical Ltd has a global presence, its products may not be widely available in certain regions. Expanding into untapped markets could help increase market share and revenue.

Opportunities

1. Growing Demand for Sleep Apnea Diagnosis: The increasing prevalence of sleep apnea and awareness of its health risks present an opportunity for Itamar Medical Ltd to expand its customer base and market share. Developing new products or improving existing ones could capture this growing demand.

2. Technological Advancements: Continuous advancements in medical technology provide an opportunity for Itamar Medical Ltd to develop and introduce new products that address unmet needs in the healthcare industry. Staying at the forefront of technological innovation can lead to a competitive advantage.

3. Strategic Partnerships: Collaborating with healthcare providers, research institutions, and other industry stakeholders can open doors to new opportunities for research, development, and market expansion. Partnerships can also enhance the company's reputation and credibility.

Threats

1. Intense Competition: The medical device industry is highly competitive, with many established companies and new entrants vying for market share. Itamar Medical Ltd must continuously innovate and maintain its technological edge to stay ahead of competitors.

2. Regulatory Constraints: Compliance with regulations and obtaining necessary approvals for medical devices can be challenging and time-consuming. Changes in regulations or delays in approvals can impact product launches and market entry.

3. Economic Volatility: Fluctuations in the global economy can affect healthcare spending, including the purchase of medical devices. Itamar Medical Ltd needs to be prepared for potential economic downturns and adapt its strategies accordingly.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Itamar Medical Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Itamar Medical historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Itamar Medical shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Itamar Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Itamar Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Itamar Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Itamar Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Itamar Medical.

Itamar Medical shareholders

%
Name
Stocks
Change
Date
6.06270 % Yaron (Giora)29,845,759123,62612/31/2020
5.75224 % MS Pace LP28,317,403-11,990,01010/27/2020
4.85700 % Migdal Insurance and Financial Holdings Ltd23,910,2602,995,58912/31/2020
3.01429 % Gerstel (Martin S)14,838,89103/15/2020
0.08097 % Glick (Gilad)398,62280,0003/15/2020
0.03507 % Krindel Sieradzki (Yaffa)172,639172,6393/15/2020
0.02031 % Biran (Ilan)100,000100,0003/15/2020
0.01883 % Florida State Board of Administration92,71692,7163/31/2021
0.01025 % Litman (Efrat)50,45250,4523/15/2020
0.00690 % Dimensional Fund Advisors, Ltd.33,96508/31/2021
1
2

Most common questions regarding Itamar Medical

What values and corporate philosophy does Itamar Medical represent?

Itamar Medical Ltd represents values of innovation, commitment to patient care, and technological advancements in the medical industry. The company's corporate philosophy focuses on providing cutting-edge solutions for the diagnosis and management of sleep apnea and other related sleep disorders. By leveraging their expertise and advanced technology, Itamar Medical Ltd aims to improve the lives of patients worldwide suffering from sleep-related conditions. With a strong emphasis on research and development, the company continuously strives to deliver high-quality and reliable products that address the unique needs of healthcare professionals and patients alike.

In which countries and regions is Itamar Medical primarily present?

Itamar Medical Ltd is primarily present in the following countries and regions: United States, Israel, Europe, and Asia.

What significant milestones has the company Itamar Medical achieved?

Itamar Medical Ltd has achieved several significant milestones. The company developed the WatchPAT™ home sleep apnea test, which revolutionized the way sleep disorders are diagnosed. It also introduced the EndoPAT™ device for assessing endothelial function, helping in the detection and prevention of cardiovascular diseases. Itamar Medical has received various regulatory approvals and certifications for its products, expanding its global reach. Additionally, the company has established strategic partnerships with key players in the healthcare industry, further enhancing its market position. Through its innovative solutions and collaborations, Itamar Medical Ltd continues to make important strides in improving sleep and cardiovascular health.

What is the history and background of the company Itamar Medical?

Itamar Medical Ltd is a renowned global medical technology company that focuses on the development, marketing, and distribution of medical devices for the diagnosis of sleep apnea and other sleep disorders. Founded in 1997, Itamar Medical has established itself as a leader in the field, providing innovative solutions backed by rigorous research and development. The company's flagship product, WatchPAT, is a cutting-edge diagnostic device that offers a convenient at-home alternative to traditional sleep studies. With its commitment to improving patients' lives and enhancing healthcare professionals' understanding of sleep-related conditions, Itamar Medical has gained recognition and trust worldwide.

Who are the main competitors of Itamar Medical in the market?

The main competitors of Itamar Medical Ltd in the market include leading companies such as ResMed Inc., Koninklijke Philips N.V., and Natus Medical Incorporated.

In which industries is Itamar Medical primarily active?

Itamar Medical Ltd is primarily active in the healthcare industry.

What is the business model of Itamar Medical?

The business model of Itamar Medical Ltd revolves around the development, manufacturing, and marketing of non-invasive medical devices for sleep apnea diagnosis and management. Itamar Medical specializes in creating innovative products that assist in the diagnosis of various sleep disorders, with a particular focus on obstructive sleep apnea. The company's flagship product, WatchPAT, is a portable and user-friendly diagnostic device that measures various physiological parameters during sleep, providing accurate and reliable results. Itamar Medical aims to enhance patient care by providing healthcare professionals with advanced diagnostic tools that improve the management and treatment of sleep-related disorders, ultimately improving patients' quality of life.

What is the P/E ratio of Itamar Medical 2024?

The P/E ratio cannot be calculated for Itamar Medical at the moment.

What is the P/S ratio of Itamar Medical 2024?

The P/S cannot be calculated for Itamar Medical currently.

What is the Quality Investing of Itamar Medical?

The Quality Investing for Itamar Medical is 6/10.

What is the revenue of Itamar Medical 2024?

The revenue cannot currently be calculated for Itamar Medical.

How high is the profit of Itamar Medical 2024?

The profit cannot currently be calculated for Itamar Medical.

What is the business model of Itamar Medical

Itamar Medical Ltd is an Israeli company that specializes in the development and manufacturing of medical devices for the diagnosis and monitoring of sleep disorders and cardiovascular diseases. The business model of Itamar Medical is based on providing innovative technologies and solutions for the healthcare industry to improve patient's quality of life and optimize medical care. One of the main divisions of Itamar Medical is sleep medicine, where the company offers a wide range of products. This includes specialized EEG sensors like the NightWatch system, which enables easy and effective monitoring of patients. Itamar Medical also offers a home screening service for sleep-related breathing disorders, where patients are sent a portable device to monitor their sleep quality. Another important segment of Itamar Medical is cardiology, where the company offers innovative devices for the diagnosis and monitoring of cardiovascular diseases. This includes the EndoPAT system, which allows doctors to measure the function of blood vessels in patients. This is an important indicator for the presence of atherosclerosis and other heart diseases. Itamar Medical also focuses on the field of clinical information systems (CIS). The company develops medical IT solutions to optimize workflows in hospitals and doctor's offices. Itamar Medical's CIS solutions help doctors and hospital staff effectively manage patient data and make critical data quickly accessible when needed. The business model of Itamar Medical is based on the development of groundbreaking technologies that advance medical progress. The company also strives for high user-friendliness and an easily accessible user interface to enable easy integration into existing systems. By collaborating with public and private healthcare institutions, Itamar Medical can offer its products and services worldwide, thus meeting the need for effective medical care. Overall, Itamar Medical has established itself as an important player in the healthcare industry by providing innovative solutions to some of the most common medical challenges. The business model includes a wide range of products and services tailored to the needs of patients and medical professionals. Whether it's sleep disorders, cardiovascular diseases, or medical IT solutions, Itamar Medical aims to improve the quality of life for patients worldwide.

What is the Itamar Medical dividend?

Itamar Medical pays a dividend of 0 USD distributed over payouts per year.

How often does Itamar Medical pay dividends?

The dividend cannot currently be calculated for Itamar Medical or the company does not pay out a dividend.

What is the Itamar Medical ISIN?

The ISIN of Itamar Medical is IL0011024580.

What is the Itamar Medical WKN?

The WKN of Itamar Medical is A1CZAF.

What is the Itamar Medical ticker?

The ticker of Itamar Medical is ITMR.TA.

How much dividend does Itamar Medical pay?

Over the past 12 months, Itamar Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Itamar Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Itamar Medical?

The current dividend yield of Itamar Medical is .

When does Itamar Medical pay dividends?

Itamar Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Itamar Medical?

Itamar Medical paid dividends every year for the past 0 years.

What is the dividend of Itamar Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Itamar Medical located?

Itamar Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Itamar Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Itamar Medical from 12/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/19/2024.

When did Itamar Medical pay the last dividend?

The last dividend was paid out on 12/19/2024.

What was the dividend of Itamar Medical in the year 2023?

In the year 2023, Itamar Medical distributed 0 USD as dividends.

In which currency does Itamar Medical pay out the dividend?

The dividends of Itamar Medical are distributed in USD.

All fundamentals about Itamar Medical

Our stock analysis for Itamar Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Itamar Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.